Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1

Liver International ◽

10.1111/j.1478-3231.2011.02725.x ◽

2011 ◽

Vol 32 ◽

pp. 27-31 ◽

Author(s):

Michael P. Manns ◽

Antoaneta A. Markova ◽

Beatriz Calle Serrano ◽

Markus Cornberg

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase Iii ◽

Treatment Naïve

Download Full-text

Treatment of chronic hepatitis C Genotype 1 (G1) infection with boceprevir (Victrelis®) in the German real-life setting: First results for treatment-naïve patients from the Novus observational study

Zeitschrift für Gastroenterologie ◽

10.1055/s-0033-1352957 ◽

2013 ◽

Vol 51 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Observational Study ◽

Chronic Hepatitis C ◽

Real Life ◽

Real Life Setting ◽

First Results ◽

Treatment Naïve

Download Full-text

Faculty of 1000 evaluation for Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717965604.793466618 ◽

2012 ◽

Author(s):

Alex Thompson

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Randomised Clinical Trial ◽

Combination Regimen ◽

Treatment Naïve

Download Full-text

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

Journal of Viral Hepatitis ◽

10.1111/jvh.12278 ◽

2014 ◽

Vol 22 (2) ◽

pp. 175-183 ◽

Author(s):

P. A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

J. K. Lim ◽

S. De Salvia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Options ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Treatment Naïve

Download Full-text

1170 PREDICTORS OF DAYS UNABLE TO WORK AMONG GENOTYPE 1 TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS: POST-HOC ANALYSES OF DATA FROM PHASE 3 ADVANCE AND ILLUMINATE STUDIES

Journal of Hepatology ◽

10.1016/s0168-8278(12)61182-9 ◽

2012 ◽

Vol 56 ◽

pp. S463

Author(s):

N. Hernandez ◽

M. Vera-Llonch ◽

J. Aggarwal ◽

M. Donepudi ◽

Z. Younossi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase 3 ◽

Treatment Naïve ◽

Post Hoc ◽

Chronic Hepatitis C Patients

Download Full-text

2010 Q2WEEK CONTROLLED-RELEASE-INTERFERON-ALPHA2B + RIBAVRIN REDUCES FLU-LIKE SYMPTOMS >50% AND PROVIDES EQUIVALENT EFFICACY IN COMPARISON TO WEEKLY PEGYLATED-INTERFERON-ALPHA2B + RIBAVIRIN IN TREATMENT-NAIVE-GENOTYPE-1-CHRONIC-HEPATITIS-C: RESULTS FROM EMPOWER, A RANDOMIZED-OPEN-LABEL-12-WEEK-COMPARISON IN 133 PATIENTS

Journal of Hepatology ◽

10.1016/s0168-8278(10)61201-9 ◽

2010 ◽

Vol 52 ◽

pp. S467 ◽

Author(s):

W.A. Long ◽

D. Takov ◽

K. Tchernev ◽

I. Kotzev ◽

A. Rigney ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Controlled Release ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Equivalent Efficacy ◽

Treatment Naïve

Download Full-text

Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials

10.1002/hep.27890 ◽

2015 ◽

Vol 62 (1) ◽

pp. 25-30 ◽

Author(s):

Saleh A. Alqahtani ◽

Nezam Afdhal ◽

Stefan Zeuzem ◽

Stuart C. Gordon ◽

Alessandra Mangia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase Iii ◽

Virus Genotype ◽

Chronic Hepatitis C Virus

Download Full-text

The value of cure associated with treating treatment‐naïve chronic hepatitis C genotype 1: Are the new all‐oral regimens good value to society?

Liver International ◽

10.1111/liv.13298 ◽

2016 ◽

Vol 37 (5) ◽

pp. 662-668 ◽

Author(s):

Zobair M. Younossi ◽

Haesuk Park ◽

Douglas Dieterich ◽

Sammy Saab ◽

Aijaz Ahmed ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Naïve

Download Full-text

1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

Journal of Hepatology ◽

10.1016/s0168-8278(12)61175-1 ◽

2012 ◽

Vol 56 ◽

pp. S460 ◽

Author(s):

H. Tatum ◽

P. Thuluvath ◽

E. Lawitz ◽

C.T. Martorell ◽

M. Demicco ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Hepatitis C Infection ◽

Ns5b Polymerase Inhibitor ◽

Treatment Naïve ◽

Polymerase Inhibitor ◽

Peginterferon Alfa ◽

Ns5b Polymerase

Download Full-text

Alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment naive japanese chronic hepatitis C patients: A randomised, double-blind, multicentre, phase iii trial

Journal of Hepatology ◽

10.1016/s0168-8278(06)80605-7 ◽

2006 ◽

Vol 44 ◽

pp. S224-S225 ◽

Author(s):

T. Sakai ◽

S. Iino ◽

T. Okuno ◽

M. Omata ◽

K. Kiyosawa ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Multicentre Phase ◽

Treatment Naïve ◽

Chronic Hepatitis C Patients

Download Full-text

Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

Annals of Internal Medicine ◽

10.7326/m15-0785 ◽

2015 ◽

Vol 163 (1) ◽

pp. 1 ◽

Author(s):

Stefan Zeuzem ◽

Reem Ghalib ◽

K. Rajender Reddy ◽

Paul J. Pockros ◽

Ziv Ben Ari ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Chronic Hepatitis C Virus ◽

Treatment Naïve

Download Full-text